miR-204-5p acts as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC) (Gao et al., 2017; Fan et al., 2023), targets anti-apoptotic protein BCL2 in prostate cancer (PCa) (Lin et al., 2017) and serves as an early diagnostic biomarker in endometrial cancer (EC) (Wu et al., 2022). This evidence concerns the gene BCL2 and prostate cancer.